Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,237 across all filing types
Latest filing 2024-09-30 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Intimation of Closure of the Trading Window is attached.
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the closure of the trading window for insiders and designated persons due to upcoming unaudited financial results for the quarter and half year ended September 30, 2024. It references regulatory compliance with insider trading regulations and informs about the trading restrictions prior to the announcement of financial results. The document does not contain any financial data, results, or detailed report content itself, but is an announcement related to trading restrictions ahead of financial disclosures. The document length is short (2032 characters), and it serves as an official notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice.
2024-09-30 English
Enclosed herewith the details of loss of share certificate.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the issuance of duplicate share certificates. It references compliance with SEBI regulations and requests brokers not to deal with the lost certificates. The content is an official notification about share certificate status, not a financial report, earnings release, or management discussion. It does not contain financial data or analysis, nor does it announce voting results or capital changes. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related announcement to the stock exchanges about share certificate issues.
2024-09-18 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the loss of share certificates and the issuance of duplicate certificates. It references compliance with SEBI regulations and requests brokers not to deal with the lost certificates. The content is regulatory in nature, related to share certificate management, and does not contain financial data, management discussion, or report publication. It is not an annual report, earnings release, or any financial report. It is also not a director's dealing or capital change announcement. The document fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2024-09-18 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of shares under an Employee Stock Options Plan (ESOP). It details the number of shares allotted, the increase in issued share capital, and compliance with SEBI regulations related to share-based employee benefits. The document includes specifics such as the date of allotment, exercise price, lock-in period, and ISIN number. It is an announcement of a capital change due to the allotment of shares under an ESOP, not a full financial report or earnings release. The content fits the category of a Share Issue/Capital Change announcement rather than a report or regulatory filing. The document length is under 5,000 characters and is a direct notification of share allotment, which aligns with the Share Issue/Capital Change (SHA) category.
2024-09-12 English
We like to inform you that the ESOP Allotment Committee of the Company at its meeting held on September 12, 2024, has approved the allotment of 1,14,750 equity shares of the face value ....
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of shares under an Employee Stock Options Plan (ESOP). It details the number of shares allotted, the increase in issued share capital, and compliance with SEBI regulations. The content focuses on the allotment of shares and changes in capital structure rather than financial results, management changes, or regulatory filings unrelated to capital. The document length is 4454 characters, which is relatively short but contains substantive information about share allotment, not just an announcement of a report. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2024-09-12 English
Updates
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the completion of the term of an Independent Director, Mr. Subramanian Ramaswamy Vaidya. It references compliance with SEBI Listing Regulations and provides details about the cessation of the director's term. There is no financial data, earnings information, or report attached or referenced as being published. The content clearly pertains to a change in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and focused solely on this announcement, confirming it is not a full report or other filing type.
2024-08-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.